Steven Davidoff Solomon writes for The New York Times, November 25, 2014
A recent judicial decision may just upend the hidden world of companies and “poison puts,” a world that frankly could use some clarity. … The “poison” is that the debt is often required to be bought back at a premium, or the company will be in a market where refinancing it is hard.